Atrás
Rango del Día
$16.33
$16.91
Rango de 52 Semanas
$16.08
$34.52
Volumen
9,254,318
Promedio 50D / 200D
$19.69
/
$22.59
Cierre Anterior
$16.15
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -8.9 | 0.4 |
| P/B | 1.4 | 2.9 |
| ROE % | -14.6 | 3.7 |
| Net Margin % | -8.5 | 3.9 |
| Rev Growth 5Y % | -1.9 | 10.0 |
| D/E | 1.6 | 0.2 |
Precio Objetivo de Analistas
Hold
$19.75
+18.9%
Low: $15.00
High: $25.00
P/E Futuro
8.6
EPS Futuro
$1.92
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
11 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$2.40
$2.36 – $2.43
|
12 B | 1 |
| FY2027 |
$2.04
$1.93 – $2.27
|
12 B | 10 |
| FY2026 |
$1.92
$1.84 – $2.03
|
11 B | 9 |
Puntos Clave
Revenue declined -1.91% annually over 5 years
Generating 323.00M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.63%
Capital efficient — spends only 4.64% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-1.91%
Revenue (1Y)5.72%
Earnings (1Y)N/A
FCF Growth (3Y)-49.96%
Calidad
Return on Equity
-14.62%
ROIC-1.43%
Net Margin-8.51%
Op. Margin-2.74%
Seguridad
Debt / Equity
1.63
Current Ratio2.31
Interest Coverage-1.06
Valoración
P/E Ratio
-8.93
P/B Ratio1.39
EV/EBITDAN/A
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.72% | Revenue Growth (3Y) | 4.18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1.91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 11.24B | Net Income (TTM) | -957.00M |
| ROE | -14.62% | ROA | -4.77% |
| Gross Margin | 30.05% | Operating Margin | -2.74% |
| Net Margin | -8.51% | Free Cash Flow (TTM) | 323.00M |
| ROIC | -1.43% | FCF Growth (3Y) | -49.96% |
| Safety | |||
| Debt / Equity | 1.63 | Current Ratio | 2.31 |
| Interest Coverage | -1.06 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | -8.93 | P/B Ratio | 1.39 |
| P/S Ratio | 0.76 | PEG Ratio | -0.27 |
| EV/EBITDA | N/A | Dividend Yield | 0.04% |
| Market Cap | 8.55B | Enterprise Value | 16.58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.24B | 10.64B | 10.36B | 10.06B | 12.15B |
| Net Income | -957.00M | -649.00M | 2.66B | -2.43B | 1.28B |
| EPS (Diluted) | -1.75 | -1.27 | 5.23 | -4.83 | 2.53 |
| Gross Profit | 3.38B | 3.98B | 4.15B | 3.55B | 4.72B |
| Operating Income | -308.00M | 14.00M | 707.00M | -2.85B | 1.35B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 20.06B | 25.78B | 28.28B | 28.29B | 33.52B |
| Total Liabilities | 13.95B | 18.76B | 19.81B | 22.39B | 24.40B |
| Shareholders' Equity | 6.13B | 6.96B | 8.40B | 5.83B | 9.08B |
| Total Debt | 10.00B | 13.45B | 14.11B | 17.20B | 18.31B |
| Cash & Equivalents | 1.97B | 1.76B | 3.08B | 1.72B | 2.95B |
| Current Assets | 6.87B | 8.85B | 9.60B | 8.01B | 8.87B |
| Current Liabilities | 2.97B | 6.51B | 6.50B | 4.75B | 4.24B |